Showing results (1911-1920 of 2,369) with videos related to

Sort By:
Pageof 237
Future Medicinal Chemistry|May 24, 2018
Isoform selectivity of harmine-conjugated 1,2,3-triazoles against human monoamine oxidaseSaqlain Haider, Manal Alhusban, Narayan D Chaurasiya, et al.
Future Medicinal Chemistry|April 20, 2018
Oxazole and thiazole analogs of sulindac for cancer preventionBini Mathew, Judith V Hobrath, Michele C Connelly, et al.
Future Medicinal Chemistry|April 20, 2018
Novel naphthalimide nitroimidazoles as multitargeting antibacterial agents against resistant Acinetobacter baumanniiJie Kang, Lavanya Gopala, Vijai Kumar Reddy Tangadanchu, et al.
Future Medicinal Chemistry|April 20, 2018
The critical role of epigallocatechin gallate in regulating mitochondrial metabolismWeimei Shi, Linfu Li, Yechun Ding, et al.
Future Medicinal Chemistry|August 2, 2018
Purin-6-one and pyrrolo[2,3-d]pyrimidin-4-one derivatives as potentiating agents of doxorubicin cytotoxicityMartin Andrs, Monika Pospisilova, Martina Seifrtova, et al.
Future Medicinal Chemistry|August 8, 2018
Promising anticancer activity of batumin: a natural polyene antibiotic produced by Pseudomonas batumiciMaria A Soldatkina, Vitalii V Klochko, Svitlana D Zagorodnya, et al.
Future Medicinal Chemistry|October 6, 2021
ISMN-loaded PLGA-PEG nanoparticles conjugated with anti-Staphylococcus aureus α-toxin inhibit Staphylococcus aureus biofilms in chronic rhinosinusitisShuman Huang, Pengpeng Ding, Sha Liu, et al.
Future Medicinal Chemistry|October 11, 2021
Sulfonamide-salicylaldehyde imines active against methicillin- and trimethoprim/sulfonamide-resistant StaphylococciMartin Krátký, Klára Konečná, Jiří Janoušek, et al.
Future Medicinal Chemistry|October 12, 2021
Ligand-based design of anticancer MMP2 inhibitors: a reviewSaptarshi Sanyal, Sk Abdul Amin, Nilanjan Adhikari, et al.
Future Medicinal Chemistry|April 25, 2022
The structural basis of effective LOX-1 inhibitionRajshekhar A Kore, Ashim K Bagchi, Kottayil I Varughese, et al.
Pageof 237